Pharmacogenomic testing can tell how a drug is likely to work in a certain person. But is it ready for rolling out to the ...
A less invasive test for Alzheimer’s is a big advance. But it’s not perfect and is not meant to screen healthy people.
Doctors can order genetic tests for people at high risk of breast cancer, and insurance often covers those, Kamal says. For ...
The researchers also found that the TriVerity severity score, which predicts the need for ICU-level care, such as mechanical ...
A new randomized study finds that a lab test that reads tumor genes can identify which patients with recurrent prostate ...
AWS, Deloitte, Microsoft and NVIDIA bring the latest in AI technology, coordination, and compute to the alliance and back with initial funding SEATTLE – Oct. 2, 2024 – Four National Cancer ...
The test uses mass spectrometry to measure several proteins to assess the likelihood that an individual has the brain amyloid pathology associated with Alzheimer's disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback